Ley glycolipid acts as a co-factor for tumor procoagulant activity

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 903-909

  Suzuki, Motoyuki ^a   Inufusa, Haruhiko ^b   Yamamoto, Shigeto ^a   Hamada, Tsuyoshi ^a   Aga, Miho ^a   Ando, Osamu ^a   Ohta, Tsunetaka ^a   Yasutomi, Masayuki ^b   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; GLYCOLIPID; LEWIS Y ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; DOG; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; PHYSIOLOGY; VERO CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOOD COAGULATION FACTORS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DOGS; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOBLOTTING; LEWIS BLOOD-GROUP SYSTEM; MEMBRANE GLYCOPROTEINS; NEOPLASMS; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 0031564103     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971210)73:6<903::AID-IJC24>3.0.CO;2-3     Document Type: Article

References (30)

1. ABE, K., MCKIBBIN, J.M. and HAKOMORI, S., The monoclonal antibody directed to difucosylated type 2 chain (Fucα1→ 2Ga1β1 → 4[Fucα1 → 3]-GlcNAc; Y determinant). J. biol. Chem., 258, 11793-11797 (1983).
2. ADACHI, T., INUFUSA, H., NAKATANI, Y., SUZUKI, M., HAMADA, T., ANDO, O., KURIMOTO, M., FUNAI, S., SHINDO, K. and YASUTOMI, M., Role of coagulant cancer antigen I and tissue factor on procoagulant activity of cancer cell surface [Abstract]. Proc. Amer. Ass. Cancer Res., 86th Ann. Meeting, 36, 92 (1995).
3. ADAMSON, A.S., FRANCIS, J.L., WITHEROW, R.O.N. and SNELL, M.E., Coagulopathy in the prostate cancer patient: prevalence and clinical relevance. Ann. roy. Coll. Surg., 75, 100-104 (1993).
4. BEVILACQUA, M.P., POBER, J.S., MAJEAU, G.R., FIERS, W., COTRAN, R.S. and GIMBRONE, M.A., Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. nat. Acad. Sci. (Wash.), 83, 4533-4537 (1986).
5. BLIGH, E.G. and DYER, W.J., A rapid method of total lipid extraction and purification. Canad. J. Biochem. Physiol., 37, 911-917 (1959).
6. CAMERER, E., KOLSTØ, A.B. and PRYDZ, H., Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Res., 81, 1-41 (1996).
7. DAVENPORT, R.D., POLAK, T.J. and KUNKEL, S.L., White cell-associated procoagulant activity induced by ABO incompatibility. Transfusion, 34, 943-949 (1994).
8. DINTER, A. and BERGER, E.G., The regulation of cell- and tissue-specific expression of glycans by glycosyltransferases. Adv. Exp. Med. Biol., 376, 53-82 (1995).
9. EDWARDS, R.L., SILVER, J. and RICKLES, F.R., Human tumor procoagulants: registry of the subcommittee on haemostasis and malignancy of the scientific and standardization committee, international society on thrombosis and haemostasis. Thrombosis Haemostasis, 69, 205-213 (1993).
10. FALANGA, A. and GORDON, S.G., Isolation and characterization of cancer procoagulant: a cysteine protease from malignant tissue. Biochemistry, 24, 5558-5567 (1985).
11. FENDERSON, B.A., HOLMES, E.H., FUKUSHI, Y. and HAKOMORI, S., Coordinate expression of X and Y haptens during murine embryogenesis. Develop. Biol., 114, 12-21 (1986).
12. GAILANI, D. and BROZE, G.J., Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul. Fibrinolysis, 4, 15-20 (1993).
13. GORDON, S.G., FRANKS, J.J. and LEWIS, B.J., Comparison of procoagulant activities in extracts of normal and malignant tissue. J. nat. Cancer Inst., 62, 773-776 (1979).
14. HAROLD, F. and DVORAK, M.D., Thrombosis and cancer. Hum. Pathol., 18, 275-284 (1987).
15. ITO, M. and YAMAGATA, T., A novel glycosphingolipid-degrading enzyme cleaves of the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids. J. biol. Chem., 261, 14278-14282 (1986).
16. KANNAGI, R., NUDELMAN, E., LEVERY, S.B. and HAKOMORI, S., A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J. biol. Chem., 257, 14865-14874 (1982).
17. LO, S.K., CHEUNG, A., ZHENG, Q. and SILVERSTEIN, R.L., Induction of tissue factor on monocytes by adhesion to endothelial cells. J. Immunol., 154, 4768-4777 (1995).
18. MANN, K.G., NESHEIM, M.E., CHURCH, W.R., HALEY, P. and KRISHNASWAMY, S., Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 76, 1-16 (1990).
19. NAITO, K. and FUJIKAWA, K., Activation of human blood coagulation factor XI independent of factor XII. J. biol. Chem., 266, 7353-7358 (1991).
20. ORNSTEIN, D.L., ZACHARSKI, L.R., MEMOLI, V.A., KISIEL, W., KUDRYK, B.J., HUNT, J., ROUSSEAU, S.M. and STUMP, D.C., Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer, 68, 1061-1067 (1991).
21. RADEMACHER, T.W., PAREKH, R.B. and DWEK, R.A., Glycobiology. Ann. Rev. Biochem., 57, 785-838 (1988).
22. RICKLES, F.R. and EDWARDS, R.L., Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood, 62, 14-31 (1983).
23. RICKLES, F.R., LEVINE, M. and EDWARDS, R.L., Hemostatic alterations in cancer patients. Cancer Metastasis Rev., 11, 237-248 (1992).
24. b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor derived cell lines. Cancer Res., 46, 1553-1561 (1986).
25. SCHWAGER, I. and JUNGI, T.W., Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood, 83, 152-160 (1994).
26. y. Hybridoma, 13, 295-301 (1994).
27. YAMAMOTO, S., HASE, S., FUKUDA, S., SANO, O. and IKENAKA, T., Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell line HBL-38. J. Biochem., 105, 547-555 (1989).
28. ZACHARSKI, L.R., WOJTUKIEWICZ, M.Z., COSTANTINI, V., ORNSTEIN, D.L. and MEMOLI, V.A., Pathways of coagulation/fibrinolysis activation in malignancy. Semin. Thrombosis Hemostasis, 18, 104-116 (1992).
29. ZUCCHELLA, M., PACCHIARINI, L., MELONI, F., BALLABIO, P., SAPORITI, A., BROCCHIERI, A. and GRIGNANI, G., Effect of interferon alpha, interferon gamma and tumor necrosis factor on the procoagulant activity of human cancer cells. Haematologica, 78, 282-286 (1993a).
30. ZUCCHELLA, M., PACCHIARINI, L., TACCONI, F., SAPORITI, A. and GRIGNANI, G., Different expression of procoagulant activity in human cancer cells cultured in vitro or in cells isolated from human tumor tissues. Thrombosis Haemostasis, 69, 335-338 (1993b).